This National Science Foundation (NSF) Cooperative Agreement under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) provides $975,713 in funding to Altyx Surgical, Inc. to develop and validate a novel, minimally invasive, mesh-free surgical device for treating stress urinary incontinence in women. The 2-year project aims to advance the surgical procedure and system from the prior Phase I proof-of-concept work, through activities including design optimization, testing, and pre-clinical studies to demonstrate safety and efficacy for eventual regulatory approval. This effort addresses a critical unmet need, as nearly 50% of women in the U.S. are affected by stress urinary incontinence, for which current surgical treatments carry various complications and risks.
Generated 8/13/24, 9:43 AM